[EN] PHENYL- SULFONYL DERIVATIVES AS MEDIATORS OF TRPA1 RECEPTOR ACTIVITY FOR THE TREATMENT OF PAIN [FR] DÉRIVÉS DE PHÉNYLSULFONYLE EN TANT QUE MÉDIATEURS DE L'ACTIVITÉ DE RÉCEPTEUR TRPA1 POUR LE TRAITEMENT DE LA DOULEUR
[EN] PHENYL- SULFONYL DERIVATIVES AS MEDIATORS OF TRPA1 RECEPTOR ACTIVITY FOR THE TREATMENT OF PAIN [FR] DÉRIVÉS DE PHÉNYLSULFONYLE EN TANT QUE MÉDIATEURS DE L'ACTIVITÉ DE RÉCEPTEUR TRPA1 POUR LE TRAITEMENT DE LA DOULEUR
Copper(I) fluoroalkoxidecomplexes bearing dinitrogen ligands were synthesized and the structure and reactivity of the complexes toward trifluoroethoxylation, pentafluoropropoxylation, and tetrafluoropropoxylation of aryl and heteroarylbromides were investigated.
Transition-Metal-Mediated Synthesis of Trifluoroethyl Aryl Ethers
作者:Zhiqiang Weng、Yangjie Huang、Ronglu Huang
DOI:10.1055/s-0035-1560054
日期:——
A series of well-definedcopper(I) fluoroalkoxidecomplexes, [(phen)2Cu][OCH2RF], have been shown to undergo trifluoroethoxylation, pentafluoropropoxylation, and tetrafluoropropoxylation with aryl and heteroarylbromides to generate the corresponding trifluoroethyl, pentafluoropropyl, and tetrafluoropropyl (hetero)aryl ethers in good to excellent yields. The reaction tolerates a variety of functional
UREA COMPOUNDS AS ACTIVATORS OF POTASSIUM CHANNELS KV7.2/7.3 USEFUL IN THE TREATMENT OF CNS AND PNS DISORDERS
申请人:[en]ANGELINI PHARMA S.P.A.
公开号:WO2024121048A1
公开(公告)日:2024-06-13
The present invention relates to compounds of formula (I) as defined in the specification capable of promoting the opening of Kv7.2/7.3 potassium channels, a pharmaceutical composition comprising them, and their use as a drug, particularly in the treatment of disorders of the central nervous system (CNS), such as, for example, epilepsy and neurodegenerative disorders, and of the peripheral nervous system (PNS), such as, for example, chronic and neuropathic pain.